30622011|t|Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and alpha-glycosidase inhibitors.
30622011|a|A novel class of fluoro-substituted tris-chalcones derivatives (5a-5i) was synthesized from phloroglucinol and corresponding benzaldehydes. A three step synthesis method was followed for the production of these tris-chalcone compounds. The structures of the newly synthesized compounds (5a-5i) were confirmed on the basis of IR, 1H NMR, 13C NMR, and elemental analysis.The compounds' inhibitory activities were tested against human carbonic anhydrase I and II isoenzymes (hCA I and hCA II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glycosidase (alpha-Gly). These chalcone derivatives had Ki values in the range of 19.58-78.73 nM for hCA I, 12.23-41.70 nM for hCA II, 1.09-6.84 nM for AChE, 8.30-32.30 nM for BChE and 0.93 +- 0.20-18.53 +- 5.06 nM against alpha-glycosidase. These results strongly support the promising nature of the tris-chalcone scaffold as selective carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and alpha-glycosidase inhibitor. Overall, due to these derivatives' inhibitory potential on the tested enzymes, they are promising drug candidates for the treatment of diseases like glaucoma, leukemia, epilepsy; Alzheimer's disease; type-2 diabetes mellitus that are associated with high enzymatic activity of carbonic anhydrase, acetylcholine esterase, butyrylcholinesterase, and alpha-glycosidase.
30622011	45	59	tris-chalcones	Chemical	-
30622011	90	110	acetylcholinesterase	Gene	43
30622011	112	133	butyrylcholinesterase	Gene	590
30622011	204	218	tris-chalcones	Chemical	-
30622011	232	237	5a-5i	Chemical	-
30622011	260	274	phloroglucinol	Chemical	MESH:D010696
30622011	293	306	benzaldehydes	Chemical	MESH:D001547
30622011	379	392	tris-chalcone	Chemical	-
30622011	455	460	5a-5i	Chemical	-
30622011	497	499	1H	Chemical	-
30622011	505	508	13C	Chemical	MESH:C000615229
30622011	594	599	human	Species	9606
30622011	600	627	carbonic anhydrase I and II	Gene	759;760
30622011	640	645	hCA I	Gene	1591
30622011	659	679	acetylcholinesterase	Gene	43
30622011	681	685	AChE	Gene	43
30622011	688	709	butyrylcholinesterase	Gene	590
30622011	711	715	BChE	Gene	590
30622011	759	767	chalcone	Chemical	MESH:D002599
30622011	829	834	hCA I	Gene	1591
30622011	880	884	AChE	Gene	43
30622011	904	908	BChE	Gene	590
30622011	1029	1042	tris-chalcone	Chemical	-
30622011	1085	1105	acetylcholinesterase	Gene	43
30622011	1107	1128	butyrylcholinesterase	Gene	590
30622011	1312	1320	glaucoma	Disease	MESH:D005901
30622011	1322	1330	leukemia	Disease	MESH:D007938
30622011	1332	1340	epilepsy	Disease	MESH:D004827
30622011	1342	1361	Alzheimer's disease	Disease	MESH:D000544
30622011	1363	1387	type-2 diabetes mellitus	Disease	MESH:D003924
30622011	1484	1505	butyrylcholinesterase	Gene	590
30622011	Association	MESH:D000544	590
30622011	Association	MESH:D003924	590
30622011	Negative_Correlation	MESH:D002599	1591
30622011	Association	MESH:D004827	590
30622011	Negative_Correlation	MESH:D002599	MESH:D003924
30622011	Association	MESH:D007938	590
30622011	Association	MESH:D005901	590

